Goldman Sachs’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-10,900
Closed -$1.15M 6742
2021
Q3
$1.15M Hold
10,900
﹤0.01% 4633
2021
Q2
$1.93M Hold
10,900
﹤0.01% 4230
2021
Q1
$1.45M Buy
+10,900
New +$1.69M ﹤0.01% 4303
2020
Q4
Sell
-42,100
Closed -$3.5M 5745
2020
Q3
$3.5M Hold
42,100
﹤0.01% 3167
2020
Q2
$3.46M Buy
+42,100
New +$2.85M ﹤0.01% 3058

Other funds holding ZLAB

Goldman Sachs's ZLAB Position: Q2 2026 in Review

Goldman Sachs increased its Zai Lab (ZLAB) stake by 1,994% in Q2 2026, buying an estimated $43.6M and bringing the position to 2,315,480 shares worth $44M. The position accounts for ﹤0.01% of the portfolio, ranked #1923.

Goldman Sachs first reported a position in ZLAB in Q3 2017 and has held it in 33 quarters since. The position peaked at $87.8M in Q3 2020. 93 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • Goldman Sachs held 2,315,480 shares of Zai Lab worth $44M as of Q2 2026.
  • Goldman Sachs bought 2,204,893 Zai Lab shares in Q2 2026, an estimated $43.6M.
  • Zai Lab made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #1923 holding.
  • Goldman Sachs first reported a position in Zai Lab in Q3 2017 and has held it in 33 quarters since.
  • Goldman Sachs's Zai Lab position peaked at $87.8M in Q3 2020.
  • 93 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.